{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=desvenlafaxine+succinate+%28DVS%29+SR&page=2", "query": { "intervention": "desvenlafaxine succinate (DVS) SR", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 30, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=desvenlafaxine+succinate+%28DVS%29+SR&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=desvenlafaxine+succinate+%28DVS%29+SR&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T01:25:47.631Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00277823", "title": "Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "DVS-SR 50 mg", "type": "DRUG" }, { "name": "DVS-SR 100 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 480, "start_date": "2006-02", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2007-12-28", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 25, "location_summary": "Beverly Hills, California • Northridge, California • Farmington, Connecticut + 21 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277823" }, { "nct_id": "NCT00696787", "title": "A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Desvenlafaxine Sustained Release (DVS SR)", "type": "DRUG" }, { "name": "Lyrica® (Pregabalin)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 125, "start_date": "2008-06", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2013-02-25", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 27, "location_summary": "Huntsville, Alabama • Roseville, California • San Diego, California + 22 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Roseville", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00696787" }, { "nct_id": "NCT00369434", "title": "Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Menopause", "Vasomotor System" ], "interventions": [ { "name": "Desvenlafaxine succinate sustained-release (DVS SR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 450, "start_date": "2006-06", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2007-06-01", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 34, "location_summary": "Montgomery, Alabama • Peoria, Arizona • Upland, California + 31 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Brooksville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00369434" }, { "nct_id": "NCT00424892", "title": "Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Desvenlafaxine Sustained Release", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": null, "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2007-12-06", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 59, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Phoenix, Arizona + 52 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00424892" }, { "nct_id": "NCT01188668", "title": "Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pharmacokinetics", "Cytochrome P-450 CYP2D6", "CYP3A4 Protein, Human" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Aripiprazole + desvenlafaxine succinate sustained release", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 38, "start_date": "2010-08", "completion_date": "2010-10", "has_results": true, "last_update_posted_date": "2011-11-07", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 2, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01188668" }, { "nct_id": "NCT00384033", "title": "Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Desvenlafaxine Succinate Sustained-Release (DVS SR)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Duloxetine 60 mg/day", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 638, "start_date": "2006-09", "completion_date": "2007-09", "has_results": true, "last_update_posted_date": "2012-03-15", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 22, "location_summary": "Beverly Hills, California • Burbank, California • Encino, California + 19 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384033" }, { "nct_id": "NCT01371721", "title": "A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "DVS SR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 269, "start_date": "2012-02", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2017-02-08", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 33, "location_summary": "Dothan, Alabama • Goodyear, Arizona • Tucson, Arizona + 26 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01371721" }, { "nct_id": "NCT00366652", "title": "Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depression", "Depressive Disorder", "Depressive Disorder, Major" ], "interventions": [ { "name": "desvenlafaxine SR", "type": "DRUG" }, { "name": "desipramine", "type": "DRUG" }, { "name": "duloxetine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 20, "start_date": "2006-09", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2007-05-28", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 1, "location_summary": "Neptune City, New Jersey", "locations": [ { "city": "Neptune City", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00366652" }, { "nct_id": "NCT00440427", "title": "Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Desvenlafaxine Sustained Release (DVS SR)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2007-02", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2007-12-05", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00440427" }, { "nct_id": "NCT00329186", "title": "Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "desvenlafaxine SR", "type": "DRUG" }, { "name": "venlafaxine ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 14, "start_date": "2006-05", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2013-02-08", "last_synced_at": "2026-10-09T01:25:47.631Z", "location_count": 1, "location_summary": "Wichita, Kansas", "locations": [ { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00329186" } ] }